AMENDED AND RESTATED LICENSE AGREEMENT dated as of December 10, 2010 by and between Unigene Laboratories, Inc. and GlaxoSmithKline LLCLicense Agreement • April 18th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Pennsylvania
Contract Type FiledApril 18th, 2011 Company Industry JurisdictionThis Amended and Restated License Agreement (the “Agreement”), dated December 10, 2010 (the “Amendment Effective Date”) is made by and between GlaxoSmithKline LLC, formerly known as SmithKline Beecham Corporation (“GSK”), a Delaware limited liability company, and Unigene Laboratories, Inc. (“Unigene”), a Delaware corporation (each a “Party” and collectively, the “Parties”).
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 16th, 2011 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Pennsylvania
Contract Type FiledMarch 16th, 2011 Company Industry JurisdictionThis Amended and Restated License Agreement (the “Agreement”), dated December 10, 2010 (the “Amendment Effective Date”) is made by and between GlaxoSmithKline LLC, formerly known as SmithKline Beecham Corporation (“GSK”), a Delaware limited liability company, and Unigene Laboratories, Inc. (“Unigene”), a Delaware corporation (each a “Party” and collectively, the “Parties”).